JOHN F HAMILTON
CIK 1252198 · VP & CFO · last filed 2024-06-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
21
Lifetime Open-Market Net
$9.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Director | 5,000 | $0.31 | $1.6K | $9.7K | 5 | 2023-06-15 |
| Aspira Women's Health Inc. (VRML) Delisted | Director | 130,208 | — | — | $0 | 9 | 2013-03-25 |
| ANESIVA, INC. (ANSV) Delisted | Director | — | — | — | $0 | 1 | 2009-02-19 |
| Assertio Therapeutics, Inc (DEPO) Delisted | VP & CFO | 205,644 | — | — | $0 | 4 | 2007-10-12 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-03-24 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +15,200 | $0 | EDGAR |
| 2010-12-10 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +13,000 | $0 | EDGAR |
| 2010-08-26 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +60,508 | $0 | EDGAR |
| 2009-02-19 | ANESIVA, INC. (ANSV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-13 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-13 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-04-11 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-10-12 | Assertio Therapeutics, Inc (DEPO) Delisted | Mixed | +100,000 | $0 | EDGAR |
| 2007-08-27 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-12 | Assertio Therapeutics, Inc (DEPO) Delisted | Exer (M) | +25,000 | $131.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.